LSE Market Access Academy

Gaining market access in the pharmaceutical industry is not easy. You need to secure effective and strategic decision-making across the entire product life cycle, as well as the cutting-edge strategies to adapt and pivot when necessary in a crowded and rapidly changing industry landscape. Importantly, you also need to reflect on how health systems are evolving and their growing concerns around efficiency, affordability and financial sustainability.
Working in conjunction with the Boston Consulting Group (BCG) and world-leading pharmaceutical companies from around the globe, LSE has created the Market Access Academy: a unique programme of bespoke lectures, workshops, illuminating case studies and distinguished guest speakers. Market Access Academy fully leverages our combined expertise and thought leadership to bring you advanced knowledge and insights, and the tools to read the market access environment, and devise the winning strategies to fully optimise access and value.